1 Product identity
Ingredient risk
1 ingredient to use with caution

Conjugated Phosphatidylserine with DHA 100 mg

BrandSwanson Ultra→Fat/Fatty Acid Capsule 7 ingredients 1 caution DSLD #181897
Net contents: 30 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-10-25
2 Ingredients (7)
IngredientGroupSafety
PhosphatidylserinePhosphatidylserineGenerally Safe
Microcrystalline CelluloseCellulose—
HypromelloseHypromellose—
MaltodextrinMaltodextrin—
SilicaSiliconGenerally Safe
Magnesium StearateMagnesiumUse with Caution
purified (deionized) WaterWater—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Phosphatidylserine — Generally Safe
⚠ May enhance anticoagulant effects
⚠ Soy allergy risk (soy-derived)
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• Nutrient
• All Other
5 Data source
DSLD ID181897
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-10-25
6 More from Swanson Ultra
View Swanson Ultra Safety Scorecard → 24 products
Albion Chelated Vanadium 5 mgAlbion Complexed Potassium 99 mgBonolive 250 mgCognizin Citicoline 500 mgD-Limonene Cold-Pressed Orange Peel Extract 250 mgEggshell Membrane
7 Cite this page
Vancouver
Pkhakadze G. Conjugated Phosphatidylserine with DHA 100 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/conjugated-phosphatidylserine-with-dha-100-mg-181897/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network